A purple and pink letter v on a white background.
April 23, 2020

Webinar Recording: Use of Fractional RF System Venus Viva™ for Management of Scars

Scars are a natural sign of skin damage. They’re traces of the skin’s attempt to heal collagen fibres. They tend to have an uneven appearance and can be undesirable for many patients. A minimally invasive solution such as our  Venus Viva™ skin resurfacing device has been clinically proven to improve the appearance of skin damage . It is designed with operator control in mind and delivers customized treatments using highly tunable parameters.

To better understand the value that Venus Viva™ can bring to businesses who are looking to address this common patient concern, we’ve turned to Dr. Maurice Adatto, the founder and medical director of SKINPULSE Dermatology and SKINPULSE Beauty Center , as he shares his experience and expertise in utilizing the Venus Viva™ system to manage scars for his patients. The recording of the live webinar is available below:

Venus Viva™ NanoFractional RF™ Skin Resurfacing

The NanoFractional RF™ applicator includes a patented tip where groups of small pins deliver energy deep into the tissue using radio frequency. The algorithm allows for random firing of electrodes that enables uniform heat distribution. There are two modes of operation for the NanoFractional RF™ applicator: Basic Mode and MD Mode. With MD mode, the operator has control of the amount of ablation and coagulation by adjusting power and pulse duration, separately. The result is a highly customizable skin resurfacing treatment that can be used for optimal outcomes for many different kinds of skin textural conditions such as acne scarring reduction, scar treatment, deep wrinkles, and rosacea. This treatment can be performed on all skin types.

To learn more about the capabilities of Venus Viva™ and explore the benefits of becoming a Venus Concept partner , contact an expert using the button below to get started today.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.